Literature DB >> 10702275

Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x(L) in osteosarcoma cells.

R Dey1, C T Moraes.   

Abstract

We explored the role of low mitochondrial membrane potential (DeltaPsim) and the lack of oxidative phosphorylation in apoptosis by assessing the susceptibility of osteosarcoma cell lines with and without mitochondrial DNA to staurosporine-induced death. Our cells without mitochondrial DNA had low DeltaPsim and no functional oxidative phosphorylation. Contrary to our expectation, these cells were more resistant to staurosporine-induced death than were the parental cells. This reduced susceptibility was associated with decreased activation of caspase 3 but not with the mitochondrial permeability transition pore or cytochrome c release from the mitochondria. Apoptosis in both cell lines was associated with an increase in DeltaPsim. Bcl-x(L) could protect both cell types against caspase 3 activation and apoptosis by a mechanism that does not appear to be mediated by mitochondrial function or modulation of DeltaPsim. Nevertheless, we found that Bcl-x(L) expression can stimulate cell respiration in cells with mitochondrial DNA. Our results showed that the lack of functional oxidative phosphorylation and/or low mitochondrial membrane potential are associated with an antiapoptotic effect, possibly contributing to the development of some types of cancer. It also reinforces a model in which Bcl-x(L) can exert an antiapoptotic effect by stimulating oxidative phosphorylation and/or inhibiting caspase activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10702275     DOI: 10.1074/jbc.275.10.7087

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  Assembly of the ribonucleoprotein complex containing the mRNA of the beta-subunit of the mitochondrial H+-ATP synthase requires the participation of two distal cis-acting elements and a complex set of cellular trans-acting proteins.

Authors:  Javier Ricart; José M Izquierdo; Carlo M Di Liegro; José M Cuezva
Journal:  Biochem J       Date:  2002-07-15       Impact factor: 3.857

2.  Dissipation of potassium and proton gradients inhibits mitochondrial hyperpolarization and cytochrome c release during neural apoptosis.

Authors:  M Poppe; C Reimertz; H Düssmann; A J Krohn; C M Luetjens; D Böckelmann; A L Nieminen; D Kögel; J H Prehn
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

Review 3.  Mitochondrial signaling pathways: a receiver/integrator organelle.

Authors:  Michael J Goldenthal; José Marín-García
Journal:  Mol Cell Biochem       Date:  2004-07       Impact factor: 3.396

4.  Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress.

Authors:  Manti Guha; Satish Srinivasan; Gopa Biswas; Narayan G Avadhani
Journal:  J Biol Chem       Date:  2007-03-13       Impact factor: 5.157

5.  Alterations of the mitochondrial proteome caused by the absence of mitochondrial DNA: A proteomic view.

Authors:  Mireille Chevallet; Pierre Lescuyer; Hélène Diemer; Alain van Dorsselaer; Emmanuelle Leize-Wagner; Thierry Rabilloud
Journal:  Electrophoresis       Date:  2006-04       Impact factor: 3.535

6.  PGC-1alpha/beta upregulation is associated with improved oxidative phosphorylation in cells harboring nonsense mtDNA mutations.

Authors:  Sarika Srivastava; John N Barrett; Carlos T Moraes
Journal:  Hum Mol Genet       Date:  2007-03-06       Impact factor: 6.150

Review 7.  A message emerging from development: the repression of mitochondrial beta-F1-ATPase expression in cancer.

Authors:  José M Cuezva; María Sánchez-Aragó; Sandra Sala; Amaya Blanco-Rivero; Alvaro D Ortega
Journal:  J Bioenerg Biomembr       Date:  2007-06       Impact factor: 2.945

8.  Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer.

Authors:  Antonio Isidoro; Marta Martínez; Pedro L Fernández; Alvaro D Ortega; Gema Santamaría; Margarita Chamorro; John C Reed; José M Cuezva
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

9.  In vivo inhibition of the mitochondrial H+-ATP synthase in neurons promotes metabolic preconditioning.

Authors:  Laura Formentini; Marta P Pereira; Laura Sánchez-Cenizo; Fulvio Santacatterina; José J Lucas; Carmen Navarro; Alberto Martínez-Serrano; José M Cuezva
Journal:  EMBO J       Date:  2014-02-12       Impact factor: 11.598

Review 10.  Restoration of mitochondria function as a target for cancer therapy.

Authors:  Tariq A Bhat; Sandeep Kumar; Ajay K Chaudhary; Neelu Yadav; Dhyan Chandra
Journal:  Drug Discov Today       Date:  2015-03-09       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.